Skip to main content

XOMA Royalty Corp

XOMADelisted Jul 14, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0000791908

XOMA Royalty Corp was delisted on Jul 14, 2026; its insiders filed their last Form 4 on Jul 16, 2026; 98 institutions reported holding it in 13F filings for Q2 2026, worth $723.7M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding XOMA Royalty Corp changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of XOMA: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4645−1
Shares6.23M6.28M+59.0K (+0.9%)
Value$138.7M$112.5M−$26.1M (−18.9%)

New holders (5)

Institutions that held XOMA Royalty Corp at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to XOMA in Q3 2022
InstitutionSharesValue% of portfolio
Eversept Partners, LP88,402$1.58M0.19%
Dimensional Fund Advisors LP32,143$576.0K0.00%
American Century Companies Inc20,410$366.0K0.00%
Barclays PLC340$6.00K0.00%
Bogart Wealth, LLC50$1.00K0.00%

Sold out (6)

Institutions that held XOMA Royalty Corp at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of XOMA in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Renaissance Technologies LLC32,800$731.0K
Ergoteles LLC25,400$566.0K
Pinz Capital Management, LP20,160$449.0K
Trexquant Investment LP15,125$337.0K
New York State Common Retirement Fund50$1.00K
Credit Suisse AG3$0